Cinthia Vila Nova Santana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cinthia Vila Nova Santana has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro Augusto Cruz
Fundaçao ProAR and (Faculdade de Medicina da) Universidade Federal da Bahia Salvador Bahia Brazil
6 shared publications - Gabriela Pimentel Pinheiro
Programa de Controle da Asma na Bahia (ProAR), Universidade Federal da Bahia, Salvador, Bahia, Brazil
5 shared publications - Luiz Alexandre Viana Magno
Medical School, Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil
4 shared publications - Débora Marques de Miranda
Department of Pediatrics, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
3 shared publications - Jamille Souza Fernandes
Center for Biological and Health Sciences, Federal University of Western Bahia, Barreiras, Bahia, Brazil
3 shared publications - Marco Aurélio Romano-Silva
Universidade Federal de Minas Gerais (UFMG)
3 shared publications
Latest Publications
- Open Access
- 22 February 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (6) , 681-683
Variants in Genes Encoding Innate Lymphoid Cells Type 2 Surface Markers Affecting Asthma and Atopy Pathologies
Summary: Genetic polymorphisms on ILC2 receptors (CD127, IL‐17RB and CRTH2) increase the asthma and atopy susceptibilities. Cohort analysis suggests that alleles' combination from ILC2 variants contributes to asthma and atopy risk.
- 22 February 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (6) , 681-683
Open AccessVariants in Genes Encoding Innate Lymphoid Cells Type 2 Surface Markers Affecting Asthma and Atopy Pathologies
Summary: Genetic polymorphisms on ILC2 receptors (CD127, IL‐17RB and CRTH2) increase the asthma and atopy susceptibilities. Cohort analysis suggests that alleles' combination from ILC2 variants contributes to asthma and atopy risk.
- Open Access
- 27 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (4) , e20250066
Influence of ADRB2 variants on bronchodilator response and asthma control in a mixed population
Objective: Given that ß2 agonists constitute the primary treatment for asthma and that treatment response varies as a result of polymorphisms in the ADRB2 gene, we sought to investigate the associations between ADRB2 gene variants and bronchodilator response (BDR) in asthma patients. Methods: A genetic database comprising 813 individuals was analyzed for variants in the ADRB2 gene. A longitudinal analysis of severe asthma patients was performed to evaluate changes in BDR over time. Results: The rs1042713, rs1042714, and rs1042717 variants were associated with age-related changes in BDR in patients with severe asthma. The G allele (rs1042714) and the A allele (rs1042717) were associated with uncontrolled asthma, with carriers of the G46/G79/A252 alleles showing a higher risk of difficult-to-control asthma. Notably, no association was found between these variants and ADRB2 expression levels. Conclusions: Our findings suggest that a genetic panel including ADRB2 variants, as well as age-related differences in BDR, is a useful complementary tool in asthma management.
- 27 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (4) , e20250066
Open AccessInfluence of ADRB2 variants on bronchodilator response and asthma control in a mixed population
Objective: Given that ß2 agonists constitute the primary treatment for asthma and that treatment response varies as a result of polymorphisms in the ADRB2 gene, we sought to investigate the associations between ADRB2 gene variants and bronchodilator response (BDR) in asthma patients. Methods: A genetic database comprising 813 individuals was analyzed for variants in the ADRB2 gene. A longitudinal analysis of severe asthma patients was performed to evaluate changes in BDR over time. Results: The rs1042713, rs1042714, and rs1042717 variants were associated with age-related changes in BDR in patients with severe asthma. The G allele (rs1042714) and the A allele (rs1042717) were associated with uncontrolled asthma, with carriers of the G46/G79/A252 alleles showing a higher risk of difficult-to-control asthma. Notably, no association was found between these variants and ADRB2 expression levels. Conclusions: Our findings suggest that a genetic panel including ADRB2 variants, as well as age-related differences in BDR, is a useful complementary tool in asthma management.
- Open Access
- 7 February 2025
- Published by Elsevier in CHEST Pulmonary
- Vol. 3 (2)
Connecting the Dots Between Asthma Control and Frailty in Older Adults With Moderate to Severe Asthma
- 7 February 2025
- Published by Elsevier in CHEST Pulmonary
- Vol. 3 (2)
Open AccessConnecting the Dots Between Asthma Control and Frailty in Older Adults With Moderate to Severe Asthma
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Obesity
- Vol. 2024 (1) , 3813621
Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity
Objective: Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity— FOXO3A (forkhead box O3), AMPK (protein kinase AMP‐activated), and POMC (proopiomelanocortin)—are associated with extreme obesity (EOB). Methods: We conducted a case–control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m 2 . We genotyped 10 single nucleotide variants (SNVs) using TaqMan‐based assays. Results: Four SNVs—rs1536057 in FOXO3A , rs103685 in AMPK , rs934778, and rs6545975 in POMC —were associated with an increased risk of EOB. The strongest association was observed with rs934778 ( POMC ), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86–9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference. Conclusions: These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.
- 1 January 2024
- Published by Wiley in Journal of Obesity
- Vol. 2024 (1) , 3813621
Open AccessGenetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity
Objective: Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity— FOXO3A (forkhead box O3), AMPK (protein kinase AMP‐activated), and POMC (proopiomelanocortin)—are associated with extreme obesity (EOB). Methods: We conducted a case–control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m 2 . We genotyped 10 single nucleotide variants (SNVs) using TaqMan‐based assays. Results: Four SNVs—rs1536057 in FOXO3A , rs103685 in AMPK , rs934778, and rs6545975 in POMC —were associated with an increased risk of EOB. The strongest association was observed with rs934778 ( POMC ), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86–9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference. Conclusions: These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.
- Open Access
- 27 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (2) , 101351
Aeroallergen sensitization patterns among patients with chronic rhinitis with or without concomitant asthma
- 27 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (2) , 101351
Open AccessAeroallergen sensitization patterns among patients with chronic rhinitis with or without concomitant asthma
- 17 July 2023
- Published by Taylor & Francis in Journal of Asthma
- Vol. 60 (12) , 2248-2251
Another case of preventable death from asthma
Background: Academic achievement (AA) is an important issue not only during the school period since it is a strong predictor of long-term professional and social success. Physical fitness (PF) components are associated with AA, and previous studies were conducted with relatively small samples, lack of statistical power, and the conclusions are based on simple correlational analyses. The objective of this study was to analyze the association between PF (single and clustered) with AA in a large and representative sample of high school students. Methods: Cross-sectional design study conducted with 911 students, aged 13–15 years (38.52% boys) enrolled in the first year of high school. Cardiorespiratory fitness (20-m shuttle run test), muscular strength (dynamometer), and body composition (skinfolds) were measured. PF components were clustered (Z-cardiorespiratory fitness + Z-muscular strength – Z-body fatness). AA was analyzed through standard math tests. Hierarchical linear regression analysis was applied to verify the independent contribution of each single component and PF’s cluster on AA. Age, screen time, maternal education, race, and type of residence were used as covariates. Results: Among boys, cardiorespiratory fitness was negatively associated with AA (β = −0.137; P = .041), while strength was positively associated with AA (β = 0.188; P = .004). There was no association between clustered PF indicators and AA (β = 0.064; P = .297). There was a negative association between age and AA in girls (β = −0.151; P = .003) and in boys (β = −0.128; P = .045). Conclusions: These results support current literature, indicating an association between PF’s component, namely muscular strength and AA (mathematics) in adolescents, even when controlled for several covariates.
- 17 July 2023
- Published by Taylor & Francis in Journal of Asthma
- Vol. 60 (12) , 2248-2251
Another case of preventable death from asthma
Background: Academic achievement (AA) is an important issue not only during the school period since it is a strong predictor of long-term professional and social success. Physical fitness (PF) components are associated with AA, and previous studies were conducted with relatively small samples, lack of statistical power, and the conclusions are based on simple correlational analyses. The objective of this study was to analyze the association between PF (single and clustered) with AA in a large and representative sample of high school students. Methods: Cross-sectional design study conducted with 911 students, aged 13–15 years (38.52% boys) enrolled in the first year of high school. Cardiorespiratory fitness (20-m shuttle run test), muscular strength (dynamometer), and body composition (skinfolds) were measured. PF components were clustered (Z-cardiorespiratory fitness + Z-muscular strength – Z-body fatness). AA was analyzed through standard math tests. Hierarchical linear regression analysis was applied to verify the independent contribution of each single component and PF’s cluster on AA. Age, screen time, maternal education, race, and type of residence were used as covariates. Results: Among boys, cardiorespiratory fitness was negatively associated with AA (β = −0.137; P = .041), while strength was positively associated with AA (β = 0.188; P = .004). There was no association between clustered PF indicators and AA (β = 0.064; P = .297). There was a negative association between age and AA in girls (β = −0.151; P = .003) and in boys (β = −0.128; P = .045). Conclusions: These results support current literature, indicating an association between PF’s component, namely muscular strength and AA (mathematics) in adolescents, even when controlled for several covariates.
- Open Access
- 20 June 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (3) , e20220465
Handgrip strength as a diagnostic tool for frailty risk in elderly patients with moderate to severe asthma
To evaluate handgrip strength (HGS) as a diagnostic tool for frailty risk in elderly patients with asthma, as well as to investigate the prevalence of frailty in this population. Methods: This was a cross-sectional study including 96 patients = 60 years of age diagnosed with moderate to severe asthma and treated at a tertiary referral center in Brazil. We measured HGS using a calibrated hydraulic hand dynamometer. We used a frailty scale and the AUC to assess the diagnostic accuracy of the HGS test. Results: The median age of participants was 67 years. Most (78%) were women and non-White (91%) of low socioeconomic status. HGS identified those at risk for frailty, with an AUC of 71.6% (61.5-80.4%; p < 0.002), as well as a sensitivity of 73.58% and a specificity of 67.53%, on the basis of a cutoff of = 19 kgf. Conclusions: HGS appears to be a simple, reliable tool for clinicians to determine frailty risk in older asthma patients in a point-of-care setting.
- 20 June 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (3) , e20220465
Open AccessHandgrip strength as a diagnostic tool for frailty risk in elderly patients with moderate to severe asthma
To evaluate handgrip strength (HGS) as a diagnostic tool for frailty risk in elderly patients with asthma, as well as to investigate the prevalence of frailty in this population. Methods: This was a cross-sectional study including 96 patients = 60 years of age diagnosed with moderate to severe asthma and treated at a tertiary referral center in Brazil. We measured HGS using a calibrated hydraulic hand dynamometer. We used a frailty scale and the AUC to assess the diagnostic accuracy of the HGS test. Results: The median age of participants was 67 years. Most (78%) were women and non-White (91%) of low socioeconomic status. HGS identified those at risk for frailty, with an AUC of 71.6% (61.5-80.4%; p < 0.002), as well as a sensitivity of 73.58% and a specificity of 67.53%, on the basis of a cutoff of = 19 kgf. Conclusions: HGS appears to be a simple, reliable tool for clinicians to determine frailty risk in older asthma patients in a point-of-care setting.
- 1 September 2015
- Published by Elsevier in Psychiatry Research
- Vol. 229 (1-2) , 586-588
Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response
- 1 September 2015
- Published by Elsevier in Psychiatry Research
- Vol. 229 (1-2) , 586-588
Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response
- 1 August 2012
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 16 (4) , 241-250
Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs
Adverse drug reactions (ADRs) associated with anti-tuberculosis (anti-TB) drug regimens have considerable impact on anti-TB treatment, potentially leading to unsuccessful outcomes. Nevertheless, the risk factors that play a role in anti-TB drug-induced ADRs are not well established. It is well documented that genetic polymorphisms in drug-metabolizing enzymes (DMEs) result in considerably complex variability in anti-TB drug disposition. In addition, the impact of pharmacogenetic variation on the metabolism of anti-TB drugs may be modifiable by environmental exposure. Thus, an assessment of pharmacogenetic variability combined with biomarkers of environmental exposure may be helpful for demonstrating the effect of the gene-environment interaction on susceptibility to ADRs induced by anti-TB drug therapy. The aim of the study was to investigate the impact of the interaction between environmental risk factors and pharmacogenetic polymorphisms in four common DMEs — N-acetyltransferase 2 (arylamine N-acetyltransferase) [NAT2], glutathione S-transferase theta 1 [GSTT1], glutathione S-transferase mu 1 [GSTM1], and cytochrome P450 2E1 [CYP2E1] — on commonly reported ADRs to first-line anti-TB drugs in 129 patients receiving homogeneous TB treatment. TB patients monitored during drug treatment were divided into subgroups according to the presence or absence of ADRs. Additionally, the patients’ clinical and demographic characteristics were collected in order to identify the environmental factors that are potential triggers for ADRs induced by anti-TB drug treatment. Pharmacogenetic variability was determined by gene sequencing, TaqMan® assays, or polymerase chain reaction. The findings of this study suggest that the NAT2 slow acetylator haplotype, female sex, and smoking are important determinants of susceptibility to ADRs induced by anti-TB drugs. Patients carrying multiple, but not single, polymorphisms in the NAT2, GSTM1, GSTT1, and CYP2E1 genes were found to have an increased risk of ADRs, as revealed by gene-gene interaction analysis. Moreover, we also identified meaningful gene-environment interaction models that resulted in the highest levels of ADR risk. The study findings provide evidence of the clinical impact of the interaction between pharmacogenetic variability and environmental factors on ADRs induced by anti-TB drug therapy. Predictive pharmacogenetic testing and a comprehensive clinical history would therefore be helpful for identification and careful monitoring of patients at high risk of this complication.
- 1 August 2012
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 16 (4) , 241-250
Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs
Adverse drug reactions (ADRs) associated with anti-tuberculosis (anti-TB) drug regimens have considerable impact on anti-TB treatment, potentially leading to unsuccessful outcomes. Nevertheless, the risk factors that play a role in anti-TB drug-induced ADRs are not well established. It is well documented that genetic polymorphisms in drug-metabolizing enzymes (DMEs) result in considerably complex variability in anti-TB drug disposition. In addition, the impact of pharmacogenetic variation on the metabolism of anti-TB drugs may be modifiable by environmental exposure. Thus, an assessment of pharmacogenetic variability combined with biomarkers of environmental exposure may be helpful for demonstrating the effect of the gene-environment interaction on susceptibility to ADRs induced by anti-TB drug therapy. The aim of the study was to investigate the impact of the interaction between environmental risk factors and pharmacogenetic polymorphisms in four common DMEs — N-acetyltransferase 2 (arylamine N-acetyltransferase) [NAT2], glutathione S-transferase theta 1 [GSTT1], glutathione S-transferase mu 1 [GSTM1], and cytochrome P450 2E1 [CYP2E1] — on commonly reported ADRs to first-line anti-TB drugs in 129 patients receiving homogeneous TB treatment. TB patients monitored during drug treatment were divided into subgroups according to the presence or absence of ADRs. Additionally, the patients’ clinical and demographic characteristics were collected in order to identify the environmental factors that are potential triggers for ADRs induced by anti-TB drug treatment. Pharmacogenetic variability was determined by gene sequencing, TaqMan® assays, or polymerase chain reaction. The findings of this study suggest that the NAT2 slow acetylator haplotype, female sex, and smoking are important determinants of susceptibility to ADRs induced by anti-TB drugs. Patients carrying multiple, but not single, polymorphisms in the NAT2, GSTM1, GSTT1, and CYP2E1 genes were found to have an increased risk of ADRs, as revealed by gene-gene interaction analysis. Moreover, we also identified meaningful gene-environment interaction models that resulted in the highest levels of ADR risk. The study findings provide evidence of the clinical impact of the interaction between pharmacogenetic variability and environmental factors on ADRs induced by anti-TB drug therapy. Predictive pharmacogenetic testing and a comprehensive clinical history would therefore be helpful for identification and careful monitoring of patients at high risk of this complication.
- 1 October 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 133 (3) , 633-637
Genetic variations in FOXO3A are associated with Bipolar Disorder without confering vulnerability for suicidal behavior
- 1 October 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 133 (3) , 633-637
Genetic variations in FOXO3A are associated with Bipolar Disorder without confering vulnerability for suicidal behavior